General Information of Drug (ID: DMZKC7S)

Drug Name
Ankinara Drug Info
Indication
Disease Entry ICD 11 Status REF
Inflammatory bowel disease DD72 Investigative [1]
Psoriasis vulgaris EA90 Investigative [1]
Rheumatoid arthritis FA20 Investigative [1]
Cross-matching ID
TTD Drug ID
DMZKC7S

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin-10 (IL10) TTT0Q1F IL10_HUMAN Activator [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Interleukin-10 (IL10) DTT IL10 5.87 4.853 5.092 5.629
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Inflammatory bowel disease
ICD Disease Classification DD72
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Interleukin-10 (IL10) DTT IL10 7.19E-03 -0.11 -0.35
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2006 May;11(2):275-91.